A molecular signature of cell invasion in breast ca

Information

  • Research Project
  • 6736371
  • ApplicationId
    6736371
  • Core Project Number
    R41CA105578
  • Full Project Number
    1R41CA105578-01
  • Serial Number
    105578
  • FOA Number
    PA-03-13
  • Sub Project Id
  • Project Start Date
    3/1/2004 - 20 years ago
  • Project End Date
    2/28/2006 - 18 years ago
  • Program Officer Name
    LIDDELL HUPPI, REBECCA
  • Budget Start Date
    3/1/2004 - 20 years ago
  • Budget End Date
    2/28/2005 - 19 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    2/12/2004 - 20 years ago
Organizations

A molecular signature of cell invasion in breast ca

DESCRIPTION (provided by applicant): The long-term objective of this research project is to unveil the molecular signature of tumor cell invasion. Tumor invasion and metastasis are complex processes involving extracellular matrix (ECM) degrading proteinase activity and cell migration through the ECMs. Since mounting evidence suggests that ras expression serves as a marker for tumor aggressiveness of breast cancer, we have investigated ras-mediated signaling pathways critical for human breast epithelial cell invasion. Our study showed that H-ras, but not N-ras, induces migrative and invasive phenotypes involving matrix metalloproteinase (MMP)-2 upregulation, while both Hand N-ras induce cell proliferation and transformation. Since ras is among the most frequently activated signaling molecules in human cancer, we hypothesize that the mRNA expression pattern differentially regulated by H-ras and N-ras reflects a signature representing invasive and migrative capability of cancer cells. To test our hypothesis, during the Phase I study we propose (Aim 1) to further investigate the molecular pathways for the ras-mediated cell migration and invasion; (Aim 2 and 3) to identify mRNA marker candidates of H-ras-mediated breast epithelial cell migration/invasion by microarrays; (Aim 4) to verify clinical relevance of differential mRNA expression profile associated with cell migration and invasion; and (Aim 5) to test feasibility of identifying phosphorylated and/or secreted protein marker candidates. The accomplishment of these aims will help us design diagnostic tools to predict primary tumors with metastatic potential.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R41
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    218410
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:218410\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    DETROIT R &D, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    DETROIT
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    48201
  • Organization District
    UNITED STATES